New York State Common Retirement Fund’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

New York State Common Retirement Fund’s Portfolio ANTH Stock Details ANTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-4,750	Closed	-$16K	–	3289
2017 Q1	$16K	Hold	4,750	–	–	﹤0.01%	3121
2016 Q4	$25K	Hold	4,750	–	–	﹤0.01%	3099
2016 Q3	$120K	Hold	4,750	–	–	﹤0.01%	2941
2016 Q2	$117K	Hold	4,750	–	–	﹤0.01%	2939
2016 Q1	$138K	Hold	4,750	–	–	﹤0.01%	2834
2015 Q4	$176K	Hold	4,750	–	–	﹤0.01%	2831
2015 Q3	$231K	Buy	4,750 +1,809	+62%	+$126K	﹤0.01%	2712
2015 Q2	$203K	Buy	+2,941	New	+$136K	﹤0.01%	2913

Other funds holding ANTH

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

ECM

Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return

New York State Common Retirement Fund's ANTH Position: Q2 2017 in Review

New York State Common Retirement Fund sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q2 2017, closing a stake of 4,750 shares — an estimated $16K sold.

New York State Common Retirement Fund first reported a position in ANTH in Q2 2015 and held it in 8 quarters. The position peaked at $231K in Q3 2015. 40 funds tracked by Wall St. Rank hold ANTH as of Q2 2017.

New York State Common Retirement Fund reported no remaining Anthera Pharmaceuticals, Inc. position as of Q2 2017 after selling out during the quarter.
New York State Common Retirement Fund sold 4,750 Anthera Pharmaceuticals, Inc. shares in Q2 2017, an estimated $16K.
New York State Common Retirement Fund first reported a position in Anthera Pharmaceuticals, Inc. in Q2 2015 and held it in 8 quarters.
New York State Common Retirement Fund's Anthera Pharmaceuticals, Inc. position peaked at $231K in Q3 2015.
40 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q2 2017.

Based on New York State Common Retirement Fund's 13F filing for Q2 2017, filed 11 Aug 2017.